| May 12, 2009 |
Forbes Medi-Tech Announces Financial Results for First Quarter Ended March 31, 2009 |
| April 29, 2009 |
Forbes Medi-Tech Receives Final Proceeds from Non-Dilutive Funding Transaction |
| April 15, 2009 |
Forbes Medi-Tech Provides Update on NASDAQ Listing |
| April 08, 2009 |
Forbes Medi-Tech Comments on Recent Stock Activity |
| March 30, 2009 |
Forbes Medi-Tech Announces Financial Results for the Year ended December 31, 2008 |
| February 10, 2009 |
Forbes Medi-Tech Provides Update on Additional Funding from Non-Dilutive Funding Transaction |
| February 09, 2009 |
Leading Healthy Lifestyle Magazine Highlights Clinically Proven Benefits of Forbes Medi-Tech's Cholesterol-Lowering Ingredient, Reducol(TM) |
| January 14, 2009 |
Forbes Medi-Tech Provides Update on TSX Listing ~Company Receives Notice of TSX Delisting Review~ |
| January 05, 2009 |
Forbes Medi-Tech Receives Extension to Compliance Deadline ~NASDAQ Extends Its Suspension of the Bid Price Requirement~ |
| November 13, 2008 |
Forbes Medi-Tech Announces Third Quarter 2008 Financial Results |
| October 22, 2008 |
Forbes Medi-Tech Receives Extension to Compliance Deadline ~NASDAQ Temporarily Suspends Enforcement of the Bid Price Requirement~ |
| October 09, 2008 |
Forbes Medi-Tech Showcases Frozen Fudge Bar Containing Its Cholesterol-Lowering Reducol(tm) Ingredient at the 2008 National Frozen & Refrigerated Foods Convention |
| September 19, 2008 |
Forbes Medi-Tech Provides Update on Nasdaq Listing Status |
| September 18, 2008 |
Forbes Medi-Tech Announces Reducol(tm) Expansion in South America with New Yogurt Drink Launched in Uruguay |
| August 21, 2008 |
Forbes Medi-Tech Continues European Expansion with Product Launch in Finland ~Reducol(TM) Product Line Expanded with the Introduction of Processed Cheese Slices~ |
| August 18, 2008 |
Forbes Medi-Tech Announces Sale of Pharmaceutical Assets ~Company Focuses on Building Its Revenue-Generating Nutraceutical Business~ |
| August 12, 2008 |
Forbes Medi-Tech Announces Second Quarter 2008 Financial Results |
| June 17, 2008 |
Forbes Medi-Tech Achieves "Minimum Bid Price Requirement" for Continued Listing on The Nasdaq Stock Market |
| June 09, 2008 |
Forbes Medi-Tech Receives Extension to Achieve Nasdaq's "Minimum Bid Price Requirement" |
| May 22, 2008 |
Forbes Medi-Tech Restructures Board by Reducing Number of Directors from Six to Four ~Greg Anderson Appointed as Director and Joe Dunne Named as Chair~ |
| May 15, 2008 |
Forbes Medi-Tech Announces Corporate Restructuring --Company To Focus Exclusively on Core Nutraceutical Business and Reduce 2008 Research and Development Expenses by Approximately $2.7 Million-- |
| May 14, 2008 |
Forbes Medi-Tech Announces First Quarter 2008 Financial Results |
| May 12, 2008 |
Forbes Medi-Tech Announces Completion of $3.8 Million Non-Dilutive Funding Transaction |
| April 24, 2008 |
Forbes Medi-Tech Announces Pharmavite Contract Renewal ~Following Strong Volume Growth in 2007, the Company Looks to Further Expand Product Line with Reducol(tm)-Based Products~ |
| April 01, 2008 |
Forbes Medi-Tech now Trading under former NASDAQ Trading Symbol 'FMTI' |
